DDX43 Antibodies

Santa Cruz Biotechnology delivers a wide array of DDX43 monoclonal antibodies for investigating DDX43's role in cellular processes. DDX43 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DDX43, a member of the DEAD-box RNA helicase family, plays a crucial role in RNA metabolism and regulation, influencing processes such as gene expression and ribosome biogenesis. DDX43's involvement in cellular stress responses has been documented through extensive research. Current studies highlight DDX43's significance in cancer development and progression. Researchers worldwide are actively investigating DDX43's potential as a therapeutic target in various pathological conditions. Understanding DDX43's molecular mechanisms can reveal new therapeutic strategies for disease treatment. DDX43 monoclonal antibodies from Santa Cruz Biotechnology enable researchers to advance scientific knowledge and contribute to breakthrough discoveries in cellular and molecular biology.